Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECISER
2024-518047-37-01Phase 4Completed
- Sponsor
- University Medical Center Groningen
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Rivastigmine patch arm with Placebo patch arm (2 arms). Started Dec 2024; status: completed.
02
Drugs
rivastigmine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2024-518047-37-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518047-37-01.